Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults By: MarketWatch August 08, 2023 at 07:29 AM EDT Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Pfizer Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults By: MarketWatch August 08, 2023 at 07:29 AM EDT Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Pfizer